Featured Event

Free CME/MOC Opioid Analgesics: Risk Evaluation and Mitigation Strategy (REMS) and the New FDA Blueprint

This activity presents you with a thorough review of the FDA’s updated educational blueprint to facilitate the evidence-based management of pain in your patients on a daily basis. The education provides tools to help you mitigate issues associated with opioid therapies, such as misuse and addiction.

Earn up to 3.0 AMA PRA Category 1 Credit ™ that meet most state Opioid requirements.

HB1 Credits are pending.

More information